Question 1

Does ProShare Advisors own SMMT stock?

Accepted Answer

Yes. As of its Q3 2026 13F, ProShare Advisors holds 27,660 shares of SMMT (Summit Therapeutics), worth $467,731.

Question 2

How many shares of SMMT does ProShare Advisors own?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors holds 27,660 shares of SMMT (Summit Therapeutics).

Question 3

What is ProShare Advisors' SMMT position worth?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors' SMMT position is worth $467,731.

Question 4

Is ProShare Advisors buying or selling SMMT?

Accepted Answer

In Q3 2026, ProShare Advisors increased its SMMT position by 2,209 shares (+8.7%).

Question 5

When did ProShare Advisors first buy SMMT?

Accepted Answer

ProShare Advisors first reported SMMT in its Q4 2020 13F and has listed it in 23 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	27,660	+8.7%	$467,731	0.0%	$16.91	26
2026-Q2	Decreased	25,451	-26.6%	$370,821	0.0%	$14.57	0
2026-Q1	Increased	34,686	+5.5%	$657,647	0.0%	$15.11	26
2025-Q4	Increased	32,881	+24.3%	$575,089	0.0%	$17.49	30
2025-Q3	Decreased	26,463	-4.6%	$546,726	0.0%	$21.16	0
2025-Q2	Decreased	27,732	-47.9%	$590,137	0.0%	$20.60	0
2025-Q1	Decreased	53,187	-12.6%	$1M	0.0%	$20.32	0
2024-Q4	Increased	60,830	+2.5%	$1.1M	0.0%	$17.89	26
2024-Q3	Increased	59,356	+0.8%	$1.3M	0.0%	$20.89	26